Press Release

CD BIOSCIENCES INTRODUCES VARIOUS SOLUTIONS FOR STUDYING APOPTOTIC CELL DEATH



CD BioSciences has recently launched comprehensive research solutions for studying cell death, particularly the apoptotic cell death.

FOR IMMEDIATE RELEASE

26/04/2023

CD BioSciences, a US-based CRO serving the global life science research community, has recently launched comprehensive research solutions for studying cell death, particularly the apoptotic cell death, which is crucial to the normal development and homeostasis of multicellular organisms.

During embryonic development, apoptosis counteracts proliferation by removing unnecessary cells to ensure normal organogenesis. In adults, apoptosis is primarily significant in counteracting unrestricted (i.e., tumor) proliferation and the cyclic involution of many endocrine-dependent tissues. Apoptosis is distinguished from necrosis by (1) the occurrence of characteristic and specific morphological changes and (2) the need for energy synthesis and protein synthesis in dying apoptotic cells to regulate specific genetic and biochemical pathways.

The morphology of apoptosis involves changes within the nucleus, within specific organelles (most notably mitochondria), and within the plasma membrane. In what was once considered a hallmark of apoptosis, the chromatin coalesces within the nucleus as DNA is first degraded into large 30-50 kb fragments and then into smaller ribosomal fragments of 180 to 200 bp. However, these nuclear alterations are not necessary for apoptosis, as their inhibition fails to prevent cell death.

The rapid time course of the apoptotic process, i.e., completion within a few hours, makes it difficult to identify large numbers of apoptotic cells at any given time. Moreover, this problem is further complicated in vivo, as the rate of apoptosis in vivo may be even slower than under experimental conditions in vitro, and the close proximity of phagocytes within normal tissues facilitates the rapid clearance of apoptotic cells.

Apoptosis is an important component of a variety of processes, and inappropriate apoptosis has been associated with a number of human diseases, including neurodegenerative diseases, ischemic injury, autoimmune diseases, and many types of cancer. Therefore, a better understanding of apoptosis is needed to facilitate basic research and medical development.

As a trusted CRO, CD BioSciences now provides comprehensive solutions covering all aspects of life science research, including the apoptotic cell death, ranging from Regulator Identification, Regulator Characterization, Mechanism Study, Phenotype Analysis, to Cell Death Characterization.

Regulator Identification identifies gene regulators participating in certain cell death signaling pathways.
Regulator Characterization studies the molecular function of certain regulators in cell death signaling pathways.
Mechanism Study investigates the mechanism of certain regulators.
Animal Model Generation produces genetically engineered animal models for research use.
Chemical Screening screens inhibitors or activators of certain types of cell death.

CD BioSciences is dedicated to assisting life science researchers focusing on cell death studies. For customers interested in more information regarding cell death solutions or other signaling pathways, please visit CD BioSciences at https://www.cd-biosciences.com/.

* For Research Use Only. Not for therapeutic or diagnostic applications.

About CD BioSciences

CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is a one-stop shop devoted to advancing signaling pathway studies for researchers. The company is committed to fulfilling all demands in the research of signaling pathways and provides high-quality reagents and comprehensive solutions to support innovative discoveries.

Tags:
CD BioSciences  |  apoptotic cell death  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays
CD BioSciences Introduces Multicolor Immunofluorescence Staining Kits for Enhanced Research
CD BioSciences Announces User-Friendly Tissue Clearing Kits and Reagents for Biomedical Research
Comprehensive Circulatory System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.